Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-24

FDA Approved: CARBAMAZEPINE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved Rising Pharma's original application for carbamazepine, a generic anticonvulsant used to treat epilepsy, trigeminal neuralgia, and bipolar diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

ORIG AP for CARBAMAZEPINE (CARBAMAZEPINE)